Evolus, Inc. (EOLS) vs 908 Devices Inc. (MASS)
A side-by-side comparison of Evolus, Inc. and 908 Devices Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EOLS
Evolus, Inc.
$7.39HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
MASS
908 Devices Inc.
$12.42HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — EOLS vs MASS
growth of $100 · dividends reinvested · last 6yEOLS +67.5% (+9.0%/yr)MASS -73.9% (-20.0%/yr)EOLS compounded faster over this window
Log scale — wide-divergence pair
EOLS MASS
EOLS vs MASS: by the numbers
- •MASS is the larger company ($510M vs $487M market cap).
- •Both run net losses; EOLS's is the smaller (-10.85% vs -56.68% net margin).
- •EOLS grew revenue faster over the past five years (32.82% vs 18.92% CAGR).
Metrics side by side
Valuation
| Metric | EOLS | MASS |
|---|---|---|
| P/S ratio | 1.54 | 8.38 |
| P/B ratio | N/A | 4.02 |
| FCF yield | N/A | 0.09% |
Profitability
| Metric | EOLS | MASS |
|---|---|---|
| Gross margin | 66.25% | 49.79% |
| Operating margin | -7.33% | -46.01% |
| Net margin | -10.85% | -56.68% |
| ROE | N/A | -27.20% |
| ROIC | -15.54% | -18.90% |
Growth (annualized)
| Metric | EOLS | MASS |
|---|---|---|
| Revenue CAGR (5Y) | 32.82% | 18.92% |
| Total return CAGR (5Y) | 0.46% | -17.66% |
Frequently asked
- Which has grown faster, EOLS or MASS?
- Over the past five years, EOLS grew revenue faster — EOLS at a 32.82% CAGR versus MASS at 18.92%.
- How have EOLS and MASS total returns compared?
- Over the past 5 years, EOLS delivered 0.46% and MASS delivered -17.66% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Evolus ROE908 Devices ROEEvolus operating margin908 Devices operating marginEvolus revenue growth908 Devices revenue growthEvolus free cash flow908 Devices free cash flow
Evolus & 908 Devices appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.